India, Sept. 2 -- image credit- shutterstock

Guided by public health imperatives, industry viability, and policy consistency with the Government of India's healthcare and manufacturing priorities, Association of Diagnostic Manufacturers of India (ADMI), a platform for the Indian In-Vitro Diagnostics (IVD) manufacturers has submitted a representation to Nirmala Sitharaman, Union Minister of Finance & Corporate Affairs and Chairperson, GST Council of India seeking a uniform 5% GST rate on both IVD equipment, diagnostic kits, and reagents.

In a representation, ADMI observed that diagnostics form the first line of care-from common fevers to non-communicable diseases (NCDs). The current GST regime imposes 18% on equipment and 12% on reagents...